Canopy Growth Corp Net Income (Loss) Attributable to Noncontrolling Interest
Canopy Growth Corp (CGC) reported Net Income (Loss) Attributable to Noncontrolling Interest of -CAD 3.74 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2025-05-30
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2023-06-30 was -3.74M CAD.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2023-03-31 was -561.00K CAD, a 105.65% decline year-over-year.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was -542.00K CAD.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for the quarter ending 2022-09-30 was -1.29M CAD.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for fiscal 2023 was -1.90M CAD.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for fiscal 2022 was -4.37M CAD, a 105.90% decline from fiscal 2021.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for fiscal 2021 was 74.10M CAD.
- Canopy Growth Corp net income (loss) attributable to noncontrolling interest for fiscal 2020 was -66.11M CAD, a 372.57% decline from fiscal 2019.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -3.74M CAD 10-Q · filed 2023-08-09 | -4.30M CAD derived: sum of 2 quarters · filed 2025-05-30 | -4.84M CAD derived: sum of 3 quarters · filed 2025-05-30 | -6.13M CAD derived: sum of 4 quarters · filed 2025-05-30 | ||||
| 2023-03-31 | -561.00K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | -1.10M CAD derived: sum of 2 quarters · filed 2025-05-30 | -2.39M CAD derived: sum of 3 quarters · filed 2025-05-30 | -1.90M CAD 10-K · filed 2025-05-30 | -31.39M CAD 10-K · filed 2023-06-22 | |||
| 2022-12-31 | -542.00K CAD 10-Q · filed 2024-02-09 | -5.14M CAD 10-Q · filed 2023-02-09 | -1.83M CAD derived: sum of 2 quarters · filed 2024-02-09 | -1.34M CAD 10-Q · filed 2024-02-09 | -19.65M CAD 10-Q · filed 2023-02-09 | 2.80M CAD derived: sum of 4 quarters · filed 2024-05-30 | ||
| 2022-09-30 | -1.29M CAD 10-Q · filed 2023-11-09 | -10.11M CAD 10-Q · filed 2022-11-09 | -794.00K CAD 10-Q · filed 2023-11-09 | -14.51M CAD 10-Q · filed 2022-11-09 | 3.34M CAD derived: sum of 3 quarters · filed 2024-05-30 | -3.23M CAD derived: sum of 4 quarters · filed 2024-05-30 | ||
| 2022-06-30 | -5.31M CAD 10-Q · filed 2023-08-09 | -4.41M CAD 10-Q · filed 2022-08-09 | 4.63M CAD derived: sum of 2 quarters · filed 2024-05-30 | -1.94M CAD derived: sum of 3 quarters · filed 2024-05-30 | -7.22M CAD derived: sum of 4 quarters · filed 2024-05-30 | |||
| 2022-03-31 | 9.94M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | 3.36M CAD derived: sum of 2 quarters · filed 2024-05-30 | -1.91M CAD derived: sum of 3 quarters · filed 2024-05-30 | -4.37M CAD 10-K · filed 2024-05-30 | -18.30M CAD 10-K · filed 2022-05-31 | |||
| 2021-12-31 | -6.57M CAD 10-Q · filed 2023-02-09 | -11.84M CAD derived: sum of 2 quarters · filed 2023-02-09 | -14.31M CAD 10-Q · filed 2023-02-09 | 68.98M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-09-30 | -5.27M CAD 10-Q · filed 2022-11-09 | -7.74M CAD 10-Q · filed 2022-11-09 | 75.55M CAD derived: sum of 3 quarters · filed 2023-06-22 | 150.68M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-06-30 | -2.46M CAD 10-Q · filed 2022-08-09 | 80.82M CAD derived: sum of 2 quarters · filed 2023-06-22 | 155.95M CAD derived: sum of 3 quarters · filed 2023-06-22 | 91.46M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-03-31 | 83.28M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 158.41M CAD derived: sum of 2 quarters · filed 2023-06-22 | 93.92M CAD derived: sum of 3 quarters · filed 2023-06-22 | 74.10M CAD 10-K · filed 2023-06-22 | ||||
| 2020-12-31 | 75.13M CAD 10-Q · filed 2022-02-09 | 10.64M CAD derived: sum of 2 quarters · filed 2022-02-09 | -9.18M CAD 10-Q · filed 2022-02-09 | -32.57M CAD derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | -64.49M CAD 10-Q · filed 2021-11-08 | -84.31M CAD 10-Q · filed 2021-11-08 | -107.70M CAD derived: sum of 3 quarters · filed 2022-05-31 | -125.98M CAD derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | -19.82M CAD 10-Q · filed 2021-08-06 | -43.20M CAD derived: sum of 2 quarters · filed 2022-05-31 | -61.48M CAD derived: sum of 3 quarters · filed 2022-05-31 | -77.75M CAD derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | -23.38M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -41.66M CAD derived: sum of 2 quarters · filed 2022-05-31 | -57.93M CAD derived: sum of 3 quarters · filed 2022-05-31 | -66.11M CAD 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | -18.28M CAD 10-Q · filed 2021-02-09 | -34.55M CAD derived: sum of 2 quarters · filed 2021-02-09 | -42.73M CAD 10-Q · filed 2021-02-09 | |||||
| 2019-09-30 | -16.27M CAD 10-Q · filed 2020-11-09 | -24.45M CAD 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -8.18M CAD 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 24.26M CAD 10-K · filed 2021-06-01 | |||||||
| 2018-03-31 | 16.22M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |